logo
The AJT Report: News and issues that affect organ and tissue transplantation
LITERATURE Watch: Implications for transplantation
How to Use mTOR Inhibitors? The Search Goes On
Steroid Withdrawal in Patients Transplanted for IgA Nephropathy—A Disease-Specific Consideration?
Defining Living Kidney Donor ESRD Risk—Looking Beyond Race and Gender
Cyclosporine A or Tacrolimus for Hepatitis C Recurrence? An Old Debate
Immunization Against Influenza: A Balancing Act
Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune-Mediated Tissue Inflammation
Surveillance Protocol Kidney Transplant Biopsies: Their Evolving Role in Clinical Practice
Evolution of the Role of the Transplant Pharmacist on the Multidisciplinary Transplant Team
Skin Cancer in Transplant Recipients, Out of the Woods. Scientific Retreat of the ITSCC and SCOPE
Mastering the Risk of HLA Antibodies in Kidney Transplantation: An Algorithm Based on Pretransplant Single-Antigen Flow Bead Techniques
Selective CD28 Blockade Attenuates Acute and Chronic Rejection of Murine Cardiac Allografts in a CTLA-4-Dependent Manner
The Potency of Allospecific Tregs Cells Appears to Correlate With T Cell Receptor Functional Avidity
Hearts From DCD Donors Display Acceptable Biventricular Function After Heart Transplantation in Pigs
The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
Steroids and Recurrent IgA Nephropathy After Kidney Transplantation
Ethnic and Gender Related Differences in the Risk of End-Stage Renal Disease After Living Kidney Donation
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression
Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four-Year Results of the Postconcept Study
Cyclosporine versus Tacrolimus Treated Liver Transplant Recipients with Chronic Hepatitis C: Outcomes Analysis of the UNOS/OPTN Database
Fibrosing Cholestatic Hepatitis in HIV/HCV Co-Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation
Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?
Patients’ Willingness to Accept Expanded Criteria Donor Liver Transplantation
Transplanting Kidneys Without Points for HLA-B Matching: Consequences of the Policy Change
The Impact of Variation in Donation After Cardiac Death Policies Among Donor Hospitals: A Regional Analysis
De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients
Relative Resistance of Human CD4+ Memory T Cells to Suppression by CD4+CD25+ Regulatory T Cells
Left Renal Vein Ligation: A Technique to Mitigate Low Portal Flow from Splenic Vein Siphon during Liver Transplantation
Do NK Cells Contribute to the Pathophysiology of Transplant-Associated Thrombotic Microangiopathy?
Investigation Update: Outbreak of Shiga Toxin-Producing E. coli O104 (STEC O104:H4) Infections Associated With Travel to Germany http://www.cdc.gov/ecoli/2011/ecoliO104/index.html
Liver Transplantation in an Adult With Sclerosing Cholangitis due to Multisystem Langerhans Cell Histiocytosis
Delineating the Picture of Renal Graft Injury in 2011
An Important Debate
Erratum
Erratum